Skip to main content

Table 1 Summary of evaluated aspects in the nine sets of reference criteria

From: Development of an explicit tool assessing potentially inappropriate medication use in Hong Kong elder patients

List name

Country

Independent of diagnosis (7/9)

Dosage (6/9)

Duration of therapy (4/9)

Disease-drug interactions (6/9)

Drug-drug interactions (7/9)

Duplication (3/9)

Alternative therapies (4/9)

Special consideration of use (4/9)

McLeod criteria

Canada

  

 

Rancourt criteria

Canada

 

  

Lindblad criteria

USA

   

    

Laroche criteria

France

 

 

Winit-Watjana criteria

Thailand

  

   

NORGEP

Norway

  

   

PRISCUS

Germany

    

STOPP version 2

Ireland

Beers criteria

USA